Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 341 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial FracturesCsimma, C.; Genant, H.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Borner, M.; Chiron, P.; Choong, P.; Cinats, J.; Courtenay, B.; Feibel, R.; Geulette, B.; Gravel, C.; Haas, N.; Raschke, M.; Hammacher, E.; van der Velde, D.; et al.
2008X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentDibbens, L.; Tarpey, P.; Hynes, K.; Bayly, M.; Scheffer, I.; Smith, R.; Bomar, J.; Sutton, E.; Vandeleur, L.; Shoubridge, C.; Edkins, S.; Turner, S.; Stevens, C.; O'Meara, S.; Tofts, C.; Barthorpe, S.; Buck, G.; Cole, J.; Halliday, K.; Jones, D.; et al.
2007Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countriesRescorla, L.; Achenbach, T.; Ivanova, M.; Dumenci, L.; Almqvist, F.; Bilenberg, N.; Bird, H.; Broberg, A.; Dobrean, A.; Dopfner, M.; Erol, N.; Forns, M.; Hannesdottir, H.; Kanbayashi, Y.; Lambert, M.; Leung, P.; Minaei, A.; Mulatu, M.; Novik, T.; Oh, K.; et al.
1997A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndromeMuenke, M.; Gripp, K.; McDonald-McGinn, D.; Gaudenz, K.; Whitaker, L.; Bartlett, S.; Markowitz, R.; Robin, N.; Nwokoro, N.; Mulvihill, J.; Losken, H.; Mulliken, J.; Guttmacher, A.; Wilroy, R.; Clarke, L.; Hollway, G.; Ades, L.; Haan, E.; Mulley, J.; Cohen, M.; et al.
2006Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaDruker, B.; Guilhot, F.; O'Brien, S.; Gathmann, I.; Kantarjian, H.; Gattermann, N.; Deininger, M.; Silver, R.; Goldman, J.; Stone, R.; Cervantes, F.; Hochhaus, A.; Powell, B.; Gabrilove, J.; Rousselot, P.; Reiffers, J.; Cornelissen, J.; Hughes, T.; Agis, H.; Fischer, T.; et al.
2007Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a marfanoid habitusRaymond, F.; Tarpey, P.; Edkins, S.; Tofts, C.; O'Meara, S.; Teague, J.; Butler, A.; Stevens, C.; Barthorpe, S.; Buck, G.; Cole, J.; Dicks, E.; Gray, K.; Harrison, R.; Hills, K.; Hinton, J.; Jones, D.; Menzies, A.; Perry, J.; Raine, K.; et al.
2020Septum resection in women with a septate uterus: a cohort studyRikken, J.F.; Verhorstert, K.W.; Emanuel, M.H.; Kuchenbecker, W.K.; Jansen, F.W.; Torrenga, B.; Schols, W.A.; Verhoeve, H.R.; Hoek, A.; Clark, T.J.; Stephenson, M.; Mol, B.W.; Van der Veen, F.; Van Wely, M.; Goddijn, M.; Bongers, M.Y.; van der Steeg, J.W.; Janssen, I.A.H.; Kapiteijn, K.; Torrance, H.L.; et al.
2016TBC1D24 genotype-phenotype correlationBalestrini, S.; Milh, M.; Castiglioni, C.; Lüthy, K.; Finelli, M.; Verstreken, P.; Cardon, A.; Stražišar, B.; Holder, J.; Lesca, G.; Mancardi, M.; Poulat, A.; Repetto, G.; Banka, S.; Bilo, L.; Birkeland, L.; Bosch, F.; Brockmann, K.; Cross, J.; Doummar, D.; et al.
2007Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardationTarpey, P.; Raymond, F.; Nguyen, L.; Rodriguez, J.; Hackett, A.; Vandeleur, L.; Smith, R.; Shoubridge, C.; Edkins, S.; Stevens, C.; O'Meara, S.; Tofts, C.; Barthorpe, S.; Buck, G.; Cole, J.; Halliday, K.; Hills, K.; Jones, D.; Mironenko, T.; Perry, J.; et al.
2019Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) studyLioufas, N.; Toussaint, N.D.; Pedagogos, E.; Elder, G.; Badve, S.V.; Pascoe, E.; Valks, A.; Hawley, C.; Block, G.A.; Boudville, N.C.; Campbell, K.; Cameron, J.D.; Chen, S.S.M.; Faull, R.J.; Holt, S.G.; Hooi, L.S.; Jackson, D.; Jardine, M.J.; Johnson, D.W.; Kerr, P.G.; et al.